Authors: Nijman, HW van Diest, PJ Poort-Keesom, RJJ von Mensdorff-Pouilly, S Verstraeten, RA Kummer, A Meijer, CJLM Melief, CJM Hilgers, J Kenemans, P

Citation: Hw. Nijman et al., T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer, EUR J OB GY, 94(1), 2001, pp. 114-120

Authors: Piek, JMJ van Diest, PJ Zweemer, RP Jansen, JW Poort-Keesom, RJJ Menko, FH Gille, JJP Jongsma, APM Pals, G Kenemans, P Verheijen, RHM

Citation: Jmj. Piek et al., Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, J PATHOLOGY, 195(4), 2001, pp. 451-456

Authors: Ryuko, K Schol, DJ Snijdewint, FGM von Mensdorff-Pouilly, S Poort-Keesom, RJJ Karuntu-Wanamarta, YA Verstraeten, RA Miyazaki, K Kenemans, P Hilgers, J

Citation: K. Ryuko et al., Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1, TUMOR BIOL, 21(4), 2000, pp. 197-210

Authors: Nijman, HW Kenemans, P Poort-Keesom, RJJ Verstraeten, RA Mensdorff-Pouilly, S Verheijen, RHM Melief, CJM Hilgers, J Meijer, CJLM

Citation: Hw. Nijman et al., Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer, EUR J OB GY, 83(2), 1999, pp. 201-206